Combination of lysine‐specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer
Cancer Medicine2020Vol. 10(1), pp. 317–324
Citations Over Time
Xiaying Chen, Zuyi Yang, Jiao Feng, Ting Duan, Ting Pan, Lili Yan, Ting Jin, Xiang Yu, Mingming Zhang, Peng Chen, Wengang Wang, Ruonan Zhang, Bi Chen, Liping Zhao, Tian Xie, Xinbing Sui
Abstract
The KDM6A/MMR classification-based subtypes of low KDM6A expression/READ, high KDM6A expression/pMMR, and COAD/pMMR were associated with poor prognosis. This classification can be a novel prognostic approach in CRC.
Related Papers
- → Inhibition of demethylases by GSK-J1/J4(2014)238 cited
- → Biological roles of LSD1 beyond its demethylase activity(2020)126 cited
- → Histone Demethylase LSD2 Acts as an E3 Ubiquitin Ligase and Inhibits Cancer Cell Growth through Promoting Proteasomal Degradation of OGT(2015)83 cited
- → KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity(2021)7 cited
- → When Is a Demethylase Not a Demethylase?(2011)